HUMA
Humacyte (HUMA)
$
44About Humacyte (HUMA)
Humacyte, Inc. engages in the business of developing and manufacturing off-the-shelf, universally implantable, bioengineered human tissues, advanced tissue constructs, and organ systems with the goal of improving the lives of patients and transforming the practice of medicine. The company was founded by Laura E. Niklason, Shannon Dahl, and Juliana L. Blum on October 13, 2004 and is headquartered in Durham, NC.
Details
Daily high
$5.55
Daily low
$5.26
Price at open
$5.38
52 Week High
$9.97
52 Week Low
$1.96
Market cap
650.2M
Dividend yield
0.00%
Volume
2.8M
Avg. volume
2.9M
P/E ratio
-4.30
Humacyte News
Details
Daily high
$5.55
Daily low
$5.26
Price at open
$5.38
52 Week High
$9.97
52 Week Low
$1.96
Market cap
650.2M
Dividend yield
0.00%
Volume
2.8M
Avg. volume
2.9M
P/E ratio
-4.30